Attractive Market Opportunities in the Indiana Homecare Enteral Feeding Formula Market by 2028: Grand View Research Inc.

 Indiana Homecare Enteral Feeding Formula Market Growth & Trends

The Indiana homecare enteral feeding formula market size is expected to reach USD 127.9 million by 2028 and is expected to expand at a CAGR of 7.6% over the forecast period, according to a new report by Grand View Research, Inc. The rapidly growing global geriatric population is susceptible to chronic medical ailments such as diabetes, neurological disorders, cardiovascular diseases, stroke, and end-stage cardiac failure, which require clinical dietary management. As per the Indiana State Health Plan, the leading causes of death are CVD, diabetes, stroke, and cancer. According to Administration for Community Living in 2016, there were 49.2 million U.S citizens above the age of 65 years and, is expected to reach 82.3 million by 2040. It experienced an increase of 33% from 2006 to 2016. The rapidly aging society and pursual of an unhealthy lifestyle enhance the disease burden imposed by the geriatric population. The growing geriatric population, rising prevalence of chronic diseases, and product innovation in the homecare therapies segment are boosting market growth.

The growing rate of globalization, increasing pursual of unhealthy lifestyle habits, minimal physical activity, increased consumption of junk food and beverages, and tobacco and alcohol consumption if leading to the high global prevalence of chronic ailments and targeted diseases. Market players are constantly focusing on drug discovery and development to curate disease-specific formulas. Clinical nutrition is increasingly being used to personalize the treatment of chronic diseases such as cancer and cystic fibrosis. For instance, in the case of cystic fibrosis, special digestive enzyme capsules are administered. The nature of this digestive enzyme could vary in individuals. Established market players such as Nestle provide personalized clinical nutrition formulations such as Deplin for depression and Metanx for diabetes. As per studies, 70% of patients suffering from depression have a low ability to activate folate, and thus the need for specialized formulations, such as Deplin, is rising. Additionally, research activities in nutrigenomics, proteomics, and metabolomics to establish links between food and genes are rising and provides the impetus to the clinical nutrition market in personalized treatment regimens.

The development of gastrointestinal disorders, such as GI hypomotility in Covid-19 positive patients, contributed to the rise in demand for enteral feeding formulations. As per several studies, the use of enteral feed formulations for patients suffering from malnutrition due to contracting Covid-19 is justified. For instance, as per an article published in the Journal of the Academy of Nutrition and Dietetics, several patients admitted to the ICU for Covid-19 treatment suffer from acute malnourishment. Therefore, the use of clinical nutrition formulations is expected to increase in hospital and home care settings during the Covid-19 pandemic.

Request a free sample copy or view report summary: Indiana Homecare Enteral Feeding Formula Market Report

Indiana Homecare Enteral Feeding Formula Market Report Highlights

• The standard formula product segment dominated the market in 2020 due to the high usage of enteral nutrition for basic clinical nutritional needs and easy commercial availability
• The intermittent feeding flow type segment dominated the market in 2020 due to the growing prevalence of neuromuscular disorders and allows greater patient mobility and physiological efficiency
• The adults' segment dominated the market in 2020 owing to the increasing prevalence of malnourishment, impaired immunity, and poor muscle strength
• The others indication segment dominated the market in 2020 owing to the growing prevalence of other chronic diseases such as COPD, cystic fibrosis, and other respiratory ailments

Access Press Release@ https://www.grandviewresearch.com/press-release/indiana-homecare-enteral-feeding-formula-market-analysis

Indiana Homecare Enteral Feeding Formula Market Segmentation

Grand View Research, Inc. has segmented the Indiana homecare enteral feeding formula market report on the basis of product, flow type, stage, and indication:

Indiana Homecare Enteral Feeding Formula Product Outlook (Revenue, USD Million, 2016 - 2028)

• Standard Formula
• Disease-specific Formula

Indiana Homecare Enteral Feeding Formula Flow Type Outlook (Revenue, USD Million, 2016 - 2028)

• Intermittent Feeding Flow
• Continuous Feeding Flow

Indiana Homecare Enteral Feeding Formula Stage Outlook (Revenue, USD Million, 2016 - 2028)

• Pediatrics
• Adults

Indiana Homecare Enteral Feeding Formula Indication Outlook (Revenue, USD Million, 2016 - 2028)

• Alzheimer’s
• Nutrition Deficiency
• Cancer Care
• Diabetes
• Chronic Kidney Disease
• Orphan Disease
• Dysphagia
• Pain Management
• Malabsorption/ GI Disorder/ Diarrhea
• Others

List of Key Players of Indiana Homecare Enteral Feeding Formula Market

• Mead Johnson & Company, LLC
• Byram Healthcare Centers, Inc.
• Real Food Blends
• Kate Farms
• Nutritional Medicinals, LLC
• Shield Healthcare, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.